Anesta/Abbott Actiq oral fentanyl may be used for chronic cancer and AIDS-related pain, FDA indicates.
ANESTA/ABBOTT ACTIQ MAY BE USED FOR BOTH CANCER AND AIDS BREAKTHROUGH PAIN episodes even though Anesta's NDA for fentanyl on a handle was based solely on data from chronic cancer pain patients, FDA Division of Anesthetic, Critical Care & Addiction Drug Products Deputy Director Curtis Wright, MD, indicated at Actiq's Sept. 17 review by the Anesthetic and Life Support Drugs Advisory Committee. "We have not, as a division, differentiated between cancer pain and other severe chronic pain requiring opioid therapy, except as pertains to matters of safety," Wright said in response to committee members' inquiries about use in AIDS patients.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth